- up to 50 percent more data throughput over the same spectrum;
- the ability to deliver 2.5 Gbps in the upstream; and
- 10 Gbps in the downstream on an existing hybrid fiber-coaxial (HFC) network.
What's next for shares of Agilent Technology.
Agilent turned in another stellar earnings results.
Previously studies already showed improvement from use of Exelixis's Cabometyx over Pfizer's Sutent in treating kidney cancer patients.
U.S. stock futures are higher on Tuesday.